Aktienanalyse zu Ulta Beauty Inc (ULTA)ULTAUlta Beauty Inc

Ulta Beauty, Inc. is a specialty United States beauty retailer and a premier beauty destination for cosmetics, fragrance, skin care products, wellness products, hair care products, and salon services. The Company's business includes a differentiated assortment of approximately 30,000 beauty products across a variety of categories and price points, as well as a variety of beauty services, including salon services, in more than 1,500 stores predominantly located in convenient, high-traffic locations. It also offers digital experience delivered through its Website, Ulta.com, and its mobile applications. The Company's brands include Ulta Beauty Collection, Morphe, Bio Ionic, Rare Beauty, Ouidad, DIBS Beauty, Medicube, Clinique, The Ordinary, about-face, Anastasia Beverly Hills, Ariana Grande, CHANEL, FENTY BEAUTY by Rihanna, It Cosmetics, LolaVie, OUAI, PAT McGRATH LABS, Tula, NYX Professional Makeup and others. It operates in the Consumer Cyclicals sector (RETAIL-RETAIL STORES, NEC industry).

Ulta Beauty Inc is a good buy right now as it has shown a solid Q2 earnings growth with net sales increasing by 8.9% year-over-year to $3 billion and an EPS of $6.55, exceeding estimates. The current price of $517.5 is below analyst targets, with a potential upside of over 20% to the lowest target of $625. However, the RSI is at 40.312, indicating potential for upward momentum as it approaches oversold territory. The main risk is the recent 16.54% year-to-date decline, which reflects broader market volatility.

25 analysts cover ULTA: 12 rate it Buy, 13 Hold and 0 Sell. The average price target is 647.83.